Loading
A phase 2 trial of AU-011 in advanced solid tumours, run by Aura Biosciences, now recruiting.
Suprachoroidal Administration in Subjects With Metastases to the Choroid is a phase 2 interventional study registered as NCT06643884 by Aura Biosciences, with 24 participants planned, started 2024-12-16 and due to reach its primary completion in 2026-11-30. Interventions recorded: AU-011, SCS Microinjector and Laser.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Aura Biosciences and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/